Feed Preview

Going Viral

Gut Microbiota in Movement Disorders

Gut Microbiota in Movement Disorders diagram by Hasegawa et al, Wikimedia
Hasegawa et al, Wikimedia

Gut microbiota has been implicated in neurodevelopment, neuroinflammatory responses, and neurological disorders. Here is the latest research on the role of gut microbiota in movement disorders.

Top 20 most recent papers
May 13, 2020

Magnetic Resonance Imaging Biomarkers Distinguish Normal Pressure Hydrocephalus From Progressive Supranuclear Palsy

Movement Disorders : Official Journal of the Movement Disorder Society
Andrea QuattroneAldo Quattrone
May 20, 2020

Online Mapping with the Deep Brain Stimulation Lead: A Novel Targeting Tool in Parkinson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Luka MilosevicAlireza Gharabaghi
May 8, 2020
Open Access

Movement Disorder Phenotypes in Children With 22q11.2 Deletion Syndrome

Movement Disorders : Official Journal of the Movement Disorder Society
Adam C CunninghamKathryn J Peall
May 18, 2020
Comment / Editorial

Can Leucine-Rich Repeat Kinase 2 Inhibition Benefit GBA-Parkinson's Disease?

Movement Disorders : Official Journal of the Movement Disorder Society
Luis Bonet-Ponce PhD, Mark R Cookson
April 30, 2020
Open Access

Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug-Naive Parkinson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Heather WilsonMarios Politis
May 2, 2020

Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism

Movement Disorders : Official Journal of the Movement Disorder Society
Derek B ArcherDavid E Vaillancourt
April 29, 2020

Structural Correlates of the Sensorimotor Cerebellum in Parkinson's Disease and Essential Tremor

Movement Disorders : Official Journal of the Movement Disorder Society
Alexander M LopezDaniel O Claassen
May 8, 2020

Precision Medicine for Parkinson's Disease: Ambroxol for Glucocerebrosidase-Associated Parkinson's Disease, First Trial Completed

Movement Disorders : Official Journal of the Movement Disorder Society
Susanne A Schneider, Roy N Alcalay
May 12, 2020

The Phenotypic and Genetic Spectrum of Paroxysmal Kinesigenic Dyskinesia in China

Movement Disorders : Official Journal of the Movement Disorder Society
Xiao-Jun HuangLi Cao
May 14, 2020
Open Access

Pedunculopontine Nucleus Microstructure Predicts Postural and Gait Symptoms in Parkinson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Chesney E CraigNicola J Ray
May 13, 2020
Open Access

A postCOVID-19 parkinsonism in the future?

Movement Disorders : Official Journal of the Movement Disorder Society
Aliaksandr V Boika
May 18, 2020

Does Urinary Retention Discriminate Multiple System Atrophy From Parkinson's Disease?

Movement Disorders : Official Journal of the Movement Disorder Society
Han-Joon Kim, Beomseok Jeon
May 16, 2020
Review

Dysregulated Brain Cholesterol Metabolism Is Linked to Neuroinflammation in Huntington's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Edith González-GuevaraJuan Carlos Martínez-Lazcano
May 24, 2020

CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories

Movement Disorders : Official Journal of the Movement Disorder Society
Stefanie LercheKathrin Brockmann
April 28, 2020
Open Access

Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Carlo WilkeDaniela Berg
May 2, 2020

Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Mihai S CirsteaSilke Appel-Cresswell
May 6, 2020

Magnetic Susceptibility Associates with Dopaminergic Deficits and Cognition in Parkinson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Yuto UchidaNoriyuki Matsukawa
May 16, 2020
Open Access

Cerebrospinal Fluid Cytokines and Neurodegeneration-Associated Proteins in Parkinson's Disease

Movement Disorders : Official Journal of the Movement Disorder Society
Ruwani S WijeyekoonCaroline H Williams-Gray
May 13, 2020
Open Access

Incidence of Anxiety in Parkinson's Disease during Coronavirus disease (COVID-19) pandemic

Movement Disorders : Official Journal of the Movement Disorder Society
Mehri SalariHelia Ashourizadeh
May 6, 2020

Novel Phenotype of 6p25 Deletion Syndrome Presenting Juvenile Parkinsonism and Brain Calcification

Movement Disorders : Official Journal of the Movement Disorder Society
Sung-Pin FanChin-Hsien Lin

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/gut-microbiota-in-movement-disorders/7ce8573c-14ce-4c0b-b390-6f3f6d30a962